Cabell Christopher
Inhibikase Therapeutics, Inc. · President & Head of R&D
Cabell Christopher is listed in public filings as officer: President & Head of R&D. This Cabell Christopher insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Inhibikase Therapeutics, Inc. (IKT). Investors use Cabell Christopher's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --676.6k shares | OtherFeb 21, 2026 | Disclosure amount unavailable338.3k shares | -- | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $1.8M900.1k shares | Grant / ExerciseJan 5, 2026 | $1.8M900.1k shares | $2.01 | -- | |
| $3.3M1.1M shares | Grant / ExerciseFeb 21, 2025 | $3.3M1.1M shares | $2.97 | -- | |
| $2.5M1.1M shares | Grant / ExerciseFeb 21, 2025 | $2.5M1.1M shares | $2.23 | -- |